Naita M Wirsik
Overview
Explore the profile of Naita M Wirsik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wirsik N, Schmidt T, Bruns C
Ann Surg Open
. 2024 Sep;
5(3):e479.
PMID: 39310347
No abstract available.
2.
Wirsik N, Kooij C, Dempster N, Crnovrsanin N, Donlon N, Uzun E, et al.
Ann Surg
. 2024 Aug;
280(5):799-807.
PMID: 39109441
Objective: To evaluate outcomes after primary surgery (PS) or neoadjuvant treatment followed by surgery (NAT/S) in cT2 staged adenocarcinomas of the esophagus (EAC) and gastroesophageal junction (GEJ), a multinational high-volume...
3.
Knipper K, Jung J, Straatman J, Brunner S, Wirsik N, Lyu S, et al.
Surgery
. 2024 Jun;
176(4):1098-1103.
PMID: 38944588
Background: Multimodal therapy regimens became the standard of care for patients with esophageal cancer, whereas surgical resection remains at the center of curative treatment modalities. Current guidelines provide no recommendations...
4.
Knipper K, Lemties J, Krey T, Lyu S, Wirsik N, Schiffmann L, et al.
BJS Open
. 2024 May;
8(3).
PMID: 38814750
Background: In contrast to the well-established multimodal therapy for localized oesophageal cancer, the metastatic stage is commonly treated only with systemic therapy as current international guidelines recommend. However, evidence suggesting...
5.
Wirsik N, Appel P, Braun A, Strowitzki M, Schleussner N, Nienhuser H, et al.
J Surg Res
. 2024 Apr;
298:176-184.
PMID: 38621351
Introduction: Renin-angiotensin-aldosterone system inhibitors (RAAS-I) have been shown to prolong overall survival in patients with liver metastasized colorectal cancer in combination with antiangiogenic treatment. The effects of RAAS-I combined with...
6.
Knipper K, Krey T, Lyu S, Jung J, Wirsik N, Fuchs H, et al.
World J Surg
. 2024 Mar;
48(6):1414-1423.
PMID: 38554145
Purpose: Patients with local recurrence of esophageal cancer have a highly decreased overall survival. There is currently no standardized treatment algorithm for this group. This retrospective cohort study aimed to...
7.
Wirsik N, Stengel S, Jung J, Sisic L, Crnovrsanin N, Nienhuser H, et al.
Br J Surg
. 2024 Jan;
111(1).
PMID: 38198152
No abstract available.
8.
Wirsik N, Schmidt T, Nienhuser H, Donlon N, de Jongh C, Uzun E, et al.
Ann Surg
. 2023 Jul;
278(5):683-691.
PMID: 37522845
Objective: The aim of this study was to explore oncologic outcomes of transhiatal gastrectomy (THG) or transthoracic esophagectomy (TTE) for neoadjuvantly treated gastroesophageal junction (GEJ) Siewert type II adenocarcinomas, a...
9.
Klupp F, Kahlert C, Franz C, Halama N, Schleussner N, Wirsik N, et al.
Int J Mol Sci
. 2021 Jul;
22(12).
PMID: 34208547
Background: Granulin is a secreted, glycosylated peptide-originated by cleavage from a precursor protein-which is involved in cell growth, tumor invasion and angiogenesis. However, the specific prognostic impact of granulin in...
10.
Wirsik N, Ehlers J, Mader L, Ilina E, Blank A, Grote A, et al.
Neuropathol Appl Neurobiol
. 2021 Mar;
47(6):768-780.
PMID: 33780024
Aims: In primary central nervous system tumours, epithelial-to-mesenchymal transition (EMT) gene expression is associated with increased malignancy. However, it has also been shown that EMT factors in gliomas are almost...